FamiCord AG (V3V.DE)

Compare

4.0000

-0.0200

(-0.50%)

At close: April 4 at 5:36:02 PM GMT+2

Key Events

Advanced Chart

Loading Chart for V3V.DE

Previous Close 4.0200
Open 4.0000
Bid 3.9800 x 45000
Ask 4.0200 x 25000
Day's Range 3.9800 - 4.0200
52 Week Range 3.8200 - 5.2500
Volume 1,242
Avg. Volume 1,199
Market Cap (intraday) 69.727M
Beta (5Y Monthly) 0.67
PE Ratio (TTM) 23.53
EPS (TTM) 0.1700
Earnings Date Apr 30, 2025
Forward Dividend & Yield --
Ex-Dividend Date Jun 5, 2019
1y Target Est 6.30

FamiCord AG engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally. It operates through Subgroup Vita 34 And Subgroup PBKM segments. The company produces and develops advanced therapies, genetic tests, and analyses for third parties. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces and manufactures viral vectors and CAR-T cells. In addition, the company provides biobanking services, such as freezing sperm and storage of adipose tissue and the isolation of cells from the stored materials. The company was formerly known as VITA 34 AG and changed its name to FamiCord AG in February 2025. FamiCord AG was founded in 1997 and is based in Leipzig, Germany.

www.famicord.com

783

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Care Facilities

Industry

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

V3V.DE

1.48%

DAX P (^GDAXI)

3.68%

1-Year Return

V3V.DE

15.61%

DAX P (^GDAXI)

12.16%

3-Year Return

V3V.DE

70.80%

DAX P (^GDAXI)

42.18%

5-Year Return

V3V.DE

63.47%

DAX P (^GDAXI)

116.69%

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

V3V.DE

FamiCord AG

4.0000

-0.50%

Mkt Cap EUR 69.727M